annual CFF:
$218.31M-$21.07M(-8.80%)Summary
- As of today (July 1, 2025), IRON annual cash flow from financing activities is $218.31 million, with the most recent change of -$21.07 million (-8.80%) on December 31, 2024.
- During the last 3 years, IRON annual CFF has risen by +$128.38 million (+142.76%).
- IRON annual CFF is now -8.80% below its all-time high of $239.38 million, reached on December 31, 2023.
Performance
IRON Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$244.25M+$215.45M(+748.18%)Summary
- As of today (July 1, 2025), IRON quarterly cash flow from financing activities is $244.25 million, with the most recent change of +$215.45 million (+748.18%) on March 1, 2025.
- Over the past year, IRON quarterly CFF has increased by +$228.35 million (+1436.17%).
- IRON quarterly CFF is now at all-time high.
Performance
IRON quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$446.67M+$228.35M(+104.60%)Summary
- As of today (July 1, 2025), IRON TTM cash flow from financing activities is $446.67 million, with the most recent change of +$228.35 million (+104.60%) on March 1, 2025.
- Over the past year, IRON TTM CFF has increased by +$268.69 million (+150.97%).
- IRON TTM CFF is now at all-time high.
Performance
IRON TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
IRON Cash from financing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -8.8% | +1436.2% | +151.0% |
3 y3 years | +142.8% | +10000.0% | +523.4% |
5 y5 years | +537.5% | +1115.5% | +2121.9% |
IRON Cash from financing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -8.8% | +142.8% | at high | >+9999.0% | at high | +530.1% |
5 y | 5-year | -8.8% | +537.5% | at high | +337.8% | at high | +523.4% |
alltime | all time | -8.8% | +537.5% | at high | +337.8% | at high | +523.4% |
IRON Cash from financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $244.25M(+748.2%) | $446.67M(+104.6%) |
Dec 2024 | $218.31M(-8.8%) | $28.80M(+6659.9%) | $218.31M(+10.7%) |
Sep 2024 | - | $426.00K(-99.8%) | $197.28M(-0.0%) |
Jun 2024 | - | $173.19M(+989.3%) | $197.31M(+10.9%) |
Mar 2024 | - | $15.90M(+104.9%) | $177.97M(-25.7%) |
Dec 2023 | $239.38M(+60.7%) | $7.76M(+1586.5%) | $239.38M(-37.1%) |
Sep 2023 | - | $460.00K(-99.7%) | $380.44M(+0.1%) |
Jun 2023 | - | $153.85M(+99.0%) | $380.00M(+68.0%) |
Mar 2023 | - | $77.31M(-48.1%) | $226.23M(+51.9%) |
Dec 2022 | $148.98M | $148.81M(>+9900.0%) | $148.98M(-245.2%) |
Sep 2022 | - | $22.00K(-74.4%) | -$102.57M(-1.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2022 | - | $86.00K(+56.4%) | -$103.84M(-1.6%) |
Mar 2022 | - | $55.00K(-100.1%) | -$105.51M(-217.3%) |
Dec 2021 | $89.93M(+162.6%) | - | - |
Dec 2021 | - | -$102.73M(+8118.4%) | $89.93M(-53.4%) |
Sep 2021 | - | -$1.25M(-20.9%) | $192.80M(-7.3%) |
Jun 2021 | - | -$1.58M(-100.8%) | $208.05M(-0.8%) |
Mar 2021 | - | $195.49M(>+9900.0%) | $209.64M(+512.1%) |
Dec 2020 | $34.25M | $141.00K(-99.0%) | $34.25M(+0.4%) |
Sep 2020 | - | $14.00M(>+9900.0%) | $34.11M(+69.7%) |
Jun 2020 | - | $9000.00(-100.0%) | $20.10M(+0.0%) |
Mar 2020 | - | $20.09M | $20.09M |
FAQ
- What is Disc Medicine annual cash flow from financing activities?
- What is the all time high annual CFF for Disc Medicine?
- What is Disc Medicine annual CFF year-on-year change?
- What is Disc Medicine quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Disc Medicine?
- What is Disc Medicine quarterly CFF year-on-year change?
- What is Disc Medicine TTM cash flow from financing activities?
- What is the all time high TTM CFF for Disc Medicine?
- What is Disc Medicine TTM CFF year-on-year change?
What is Disc Medicine annual cash flow from financing activities?
The current annual CFF of IRON is $218.31M
What is the all time high annual CFF for Disc Medicine?
Disc Medicine all-time high annual cash flow from financing activities is $239.38M
What is Disc Medicine annual CFF year-on-year change?
Over the past year, IRON annual cash flow from financing activities has changed by -$21.07M (-8.80%)
What is Disc Medicine quarterly cash flow from financing activities?
The current quarterly CFF of IRON is $244.25M
What is the all time high quarterly CFF for Disc Medicine?
Disc Medicine all-time high quarterly cash flow from financing activities is $244.25M
What is Disc Medicine quarterly CFF year-on-year change?
Over the past year, IRON quarterly cash flow from financing activities has changed by +$228.35M (+1436.17%)
What is Disc Medicine TTM cash flow from financing activities?
The current TTM CFF of IRON is $446.67M
What is the all time high TTM CFF for Disc Medicine?
Disc Medicine all-time high TTM cash flow from financing activities is $446.67M
What is Disc Medicine TTM CFF year-on-year change?
Over the past year, IRON TTM cash flow from financing activities has changed by +$268.69M (+150.97%)